Kratos Regains Ground but Analysts Keep Cutting Targets

KTOS has bounced 6% this week to $41.32, but that recovery still trails the median 7% gain across its closest peers, and the analyst community spent the week moving in only one direction on price.

Among the unmanned-systems cluster, AVAV and RCAT both added roughly 7.7% on the week, while VOYG surged 13.8%. Kratos kept pace but did not lead. Its short interest of 5.9% of free float sits in a comparable range to several peers, though the borrow market remains loose with availability around 848%, meaning shares to borrow are far from scarce relative to what is already out on loan. Cost to borrow has climbed 29% over the past week to 0.44%, still low in absolute terms but the sharpest upward move in the past month, a signal worth monitoring as the stock approaches next week's earnings print.

The options market tells a distinctly bullish story. The put/call ratio has dropped to 0.31, the lowest reading of the past 52 weeks, sitting 1.3 standard deviations below its 20-day average of 0.36. Six weeks ago the ratio was near 0.48. The shift is consistent: every session since late September has seen the ratio move lower, pointing to rising call demand and diminishing appetite for downside protection as the stock has stabilised above $40.

The analyst picture is where the tension sits. Piper Sandler cut its target to $61 from $75 on October 23, keeping an Overweight rating. That follows Goldman Sachs trimming to $77 from $88 on October 12, also with a Buy intact. Oppenheimer initiated at $50 Outperform on October 22, joining Macquarie at $70 and Barclays at $90, both fresh initiations this month. The pattern is consistent with what was noted here last week: every firm holds a positive rating, but targets are being walked down to meet the stock rather than the reverse. The mean target now stands at $94.44, which implies more than 100% upside from current levels. That gap looks implausible without a strong re-rating catalyst and may reflect the lag as older, higher targets are yet to be revised. Kratos ranks in the 100th percentile on analyst recommendation differential, meaning the Street's rating relative to its history has never been more positively skewed, yet the stock has lost 9.4% over the past month.

Insider activity adds a cautionary note, though it deserves context. Net selling over the past 90 days amounts to roughly $23.9 million across 382,013 shares. Every disclosed transaction was executed under a pre-arranged 10b5-1 plan, which means the trades were scheduled in advance and carry limited read-through on real-time conviction. The CFO sold in September, as did the General Counsel and the STC Division President in both September and October, all under the same plan structure. Planned sales at these prices, down roughly 45% year to date, suggest the plans were set when the stock was considerably higher.

The next earnings report is scheduled for November 4. The two most recent prints produced day-one gains of approximately 10.7% and 12.5%, with five-day moves of 23% and 29.5% respectively. The setup going in this time differs: the stock has given back most of those post-earnings gains and then some, sitting near where it was before either release. What matters on November 4 is whether management narrows or widens the gap between the $94 consensus target and a $41 stock price, specifically through any update on the four transition-stage programs and on whether capital expenditure guidance for 2026 is tracking the $125-$135 million flagged earlier in the year.